Development of Controllable Simvastatin-Releasing PLGA/β-TCP Composite Microspheres Sintered Scaffolds as Synthetic Bone Substitutes

Publisher： Trans Tech Publications

E-ISSN： 1662-9795|2017|758|126-131

ISSN： 1013-9826

Source： Key Engineering Materials, Vol.2017, Iss.758, 2017-12, pp. : 126-131

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

The bone remodeling process plays an essential part of the calcium homeostatic system and provides a crucial mechanism for adaptation to physical stress, the repair of damaged bone and the removal of old bone. We reported previously that sustainable release of simvastatin (SIM) from poly (lactic-co-glycolic acid) (PLGA) formulations could induce bone formation. The aim of this study was to develop a simvastatin-releasing PLGA/β-TCP composite microspheres (β-SPMs) sintered scaffolds (β-SPMSS) as a synthetic bone substitute, and investigate the influence of the dissolution medium on the drug release capabilities of these device based on a physicochemical model for bone remodeling. X-ray diffraction analysis (XRD) results showed β-TCP and SIM could be encapsulated into the PLGA microspheres. The β-SPMs and the β-SPMSS were able to produce sustained release of SIM for 1 month in simulated body fluid (SBF), whereas these composites released SIM for 10 days in acetate buffer (AB). The release rate of SIM from β-SPMSS in AB was faster than in SBF, indicating that the β-SPMSS could control drug release with bone cells activity response, and could be used as a scaffold in bone remodeling area. These results suggested that the β-SPMSS could release SIM sustainably, with bone cells activity response, and could be used as a scaffold in bone remodeling area.